Potomac Health News: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Potomac Health News.

Press releases published on October 7, 2026

4 hours ago

BioNexus to Build AI Applications for Malaysian Healthcare Under Exclusive CogniAI Licence

Indeterminate GlobeNewswire

4 hours ago

Progyny, Inc. Selling Season Pacing to Record Level, Revealing Critical Insights on Latest Market Dynamics

Indeterminate GlobeNewswire

4 hours ago

SciSparc: Subsidiary NeuroThera Labs’ CliniQuantum Reports Successful Quantum-Enabled Analysis of Billions of Gene Combinations Using Real-World Clinical Data on an S&P 500 Company’s Quantum Architecture

Indeterminate GlobeNewswire

4 hours ago

Guelph psychotherapist preparing to ask Queen’s Park for OHIP coverage of psychotherapy

Indeterminate GlobeNewswire

4 hours ago

FDA Grants SeaStar Medical Breakthrough Device Designation for its SCD Therapy for the Treatment of Hyperinflammation in Adult Patients with Sepsis or a Septic Condition

Indeterminate GlobeNewswire

4 hours ago

MAIA Biotechnology Achieves Patient Enrollment Milestones in Ongoing Phase 2 and Pivotal Phase 3 Clinical Trials in Non-Small Cell Lung Cancer

Indeterminate GlobeNewswire

4 hours ago

VivoSim Labs Celebrates Updated FDA Regulations Allowing Greater use of Non-Animal Testing Methods

Indeterminate GlobeNewswire

4 hours ago

Byondis to Profile Potential of Platform Technologies at World ADC San Diego, Advancing Strategy to Lead the Antibody-Drug Conjugate Field

Indeterminate GlobeNewswire

4 hours ago

Rezera Announces Positive RESOLVE-2 Phase 2 Clinical Trial Results Demonstrating Favorable Safety and Tolerability Profile for Ruvonoflast in Combination with Semaglutide

Indeterminate GlobeNewswire

4 hours ago

Pacira BioSciences and Caregiver Action Network Announce New Survey on Gaps in Preparing Families for Postsurgical Recovery at Home

Indeterminate GlobeNewswire

4 hours ago

Bexorg Awarded Up to $28.3 Million from ARPA-H to Advance Human Brain Translational Pharmacology for CNS Drug Development

Indeterminate GlobeNewswire

4 hours ago

AltruBio to Present Data from ALTB-268 Phase 2a Trial on Ulcerative Colitis at United European Gastroenterology (UEG) Week 2026

Indeterminate GlobeNewswire

4 hours ago

Kyverna Therapeutics to Present Positive Data in Stiff Person Syndrome and Progressive Multiple Sclerosis at MSToronto2026

Indeterminate GlobeNewswire

4 hours ago

Kaléo Awarded $96.1 Million BARDA Contract to Advance 2-PAM Auto-Injector for U.S. Chemical Threat Preparedness

Indeterminate GlobeNewswire

4 hours ago

Jasper Therapeutics Announces Commencement of an Offer to Purchase Outstanding Warrants

Indeterminate GlobeNewswire

4 hours ago

Atsena Presents Positive Preliminary Safety and Efficacy Results from Parts A and B of the Phase 1/2/3 LIGHTHOUSE Trial Evaluating ATSN-201 in Patients with X-linked Retinoschisis

Indeterminate GlobeNewswire

4 hours ago

Cerevance Announces Positive Phase 3 ARISE Results: Once-daily Oral Solengepras Meets Primary Endpoint and Demonstrates Motor and Non-motor Benefits in Parkinson's Disease

Indeterminate GlobeNewswire

4 hours ago

Akebia Therapeutics to Conduct Investor Meetings at the Virtual U.S. Bancorp I BTIG Kidney Health Forum

Indeterminate GlobeNewswire

5 hours ago

BrewDog Rallies Beer Lovers Across the UK to Choose Craft

Indeterminate GlobeNewswire

5 hours ago

Caspian Therapeutics and Kura Oncology to Host Investor Webcast Highlighting Caspian’s Launch and KO-7246 Preclinical Data in Diabetes

Indeterminate GlobeNewswire